Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIMALVAC phase 1 trial
PACTR201610001796177Phase 1Recruiting
- Sponsor
- Inserm
- Start
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 1 trial of PRIMVAC and sodium chloride in malaria and Placental Malaria (PM) (7 arms), sponsored by Inserm. Primary endpoint: Primary safety endpoint. Started Jan 2016; status: recruiting.
02
Drugs
PRIMVACsodium chloride
03
Conditions
malariaPlacental Malaria (PM)
Beyond the preview
Go deeper on PACTR201610001796177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201610001796177.